Search

Daniel Pm Wicklund

Examiner (ID: 10795, Phone: (571)270-7508 , Office: P/2833 )

Most Active Art Unit
2833
Art Unit(s)
2833, 2844
Total Applications
376
Issued Applications
278
Pending Applications
0
Abandoned Applications
98

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16390978 [patent_doc_number] => 20200331919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio [patent_app_type] => utility [patent_app_number] => 16/918772 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/918772
Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio Jun 30, 2020 Abandoned
Array ( [id] => 17850363 [patent_doc_number] => 20220280404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => HAIR COSMETIC [patent_app_type] => utility [patent_app_number] => 17/625474 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625474
Hair cosmetic Jun 30, 2020 Issued
Array ( [id] => 18018934 [patent_doc_number] => 20220370433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHOD FOR PRODUCING ACTIVE AGENT ADMINISTERING SYSTEMS BY MEANS OF PAD PRINTING PROCESSES [patent_app_type] => utility [patent_app_number] => 17/622531 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622531 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/622531
Method for producing active agent administering systems by means of pad printing processes Jun 25, 2020 Issued
Array ( [id] => 19929716 [patent_doc_number] => 12302906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Feed stuff for beneficial organisms that can be used in integrated pest management [patent_app_type] => utility [patent_app_number] => 17/631659 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 0 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/631659
Feed stuff for beneficial organisms that can be used in integrated pest management Jun 25, 2020 Issued
Array ( [id] => 17836439 [patent_doc_number] => 20220273744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => Process and Apparatus for Production of a Granular Cannabinoid Material Essentially Soluble in Aqueous Medium [patent_app_type] => utility [patent_app_number] => 17/629867 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629867
Process and apparatus for production of a granular cannabinoid material essentially soluble in aqueous medium Jun 22, 2020 Issued
Array ( [id] => 16581410 [patent_doc_number] => 20210015812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => Methods for Treating Antipsychotic-Induced Weight Gain [patent_app_type] => utility [patent_app_number] => 16/899708 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899708 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899708
Methods for treating antipsychotic-induced weight gain Jun 11, 2020 Issued
Array ( [id] => 17161698 [patent_doc_number] => 11147780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Multidrug pain management package [patent_app_type] => utility [patent_app_number] => 16/899465 [patent_app_country] => US [patent_app_date] => 2020-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899465 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899465
Multidrug pain management package Jun 10, 2020 Issued
Array ( [id] => 17760184 [patent_doc_number] => 20220233796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT [patent_app_type] => utility [patent_app_number] => 17/617853 [patent_app_country] => US [patent_app_date] => 2020-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617853 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617853
METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT Jun 7, 2020 Pending
Array ( [id] => 17881159 [patent_doc_number] => 20220296636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => Carbon Monoxide as a Treatment for Neurodegenerative Disease [patent_app_type] => utility [patent_app_number] => 17/616110 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/616110
Carbon monoxide as a treatment for neurodegenerative disease Jun 4, 2020 Issued
Array ( [id] => 16839342 [patent_doc_number] => 20210147354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/891898 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891898 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/891898
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION Jun 2, 2020 Abandoned
Array ( [id] => 16877960 [patent_doc_number] => 11028093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors [patent_app_type] => utility [patent_app_number] => 16/890663 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 412 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890663 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890663
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Jun 1, 2020 Issued
Array ( [id] => 16451091 [patent_doc_number] => 20200360517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => NUTRITIONAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/881597 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/881597
Nutritional composition May 21, 2020 Issued
Array ( [id] => 16296136 [patent_doc_number] => 20200281859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => ANHYDROUS DASATINIB-CONTAINING PREPARATION [patent_app_type] => utility [patent_app_number] => 16/879408 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5986 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879408 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/879408
Anhydrous dasatinib-containing preparation May 19, 2020 Issued
Array ( [id] => 18201238 [patent_doc_number] => 11583611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Biocompatible phase invertible proteinaceous compositions and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 16/878061 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6696 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878061 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878061
Biocompatible phase invertible proteinaceous compositions and methods for making and using the same May 18, 2020 Issued
Array ( [id] => 17799017 [patent_doc_number] => 11413283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Topical formulations for delivery of hedgehog inhibitor compounds and use thereof [patent_app_type] => utility [patent_app_number] => 16/878301 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 23679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878301 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878301
Topical formulations for delivery of hedgehog inhibitor compounds and use thereof May 18, 2020 Issued
Array ( [id] => 17910422 [patent_doc_number] => 20220312816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => PREPARATION FOR USE IN ENHANCING FORMATION OF SHORT-CHAIN FATTY ACIDS (SCFAS) [patent_app_type] => utility [patent_app_number] => 17/612755 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612755
Preparation for use in enhancing formation of short-chain fatty acids (SCFAs) May 17, 2020 Issued
Array ( [id] => 16282753 [patent_doc_number] => 20200276355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875543 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875543
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 16282754 [patent_doc_number] => 20200276356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875554 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875554 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875554
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 20156922 [patent_doc_number] => 12383520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-12 [patent_title] => Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder [patent_app_type] => utility [patent_app_number] => 17/610366 [patent_app_country] => US [patent_app_date] => 2020-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610366
Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder May 11, 2020 Issued
Array ( [id] => 20491523 [patent_doc_number] => 12533378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Treatment of adverse effects caused by atypical antipsychotics [patent_app_type] => utility [patent_app_number] => 17/995581 [patent_app_country] => US [patent_app_date] => 2020-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 3197 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995581 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995581
Treatment of adverse effects caused by atypical antipsychotics May 9, 2020 Issued
Menu